Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

Core Viewpoint - Quipt Home Medical Corp. has received shareholder approval for a plan of arrangement involving the acquisition of all outstanding shares by affiliates of Kingswood Capital Management and Forager Capital Management for cash consideration of US$3.65 per share [1][2]. Group 1: Shareholder Meeting and Voting Results - The special meeting of shareholders was held on March 3, 2026, in Sarasota, Florida, where the Arrangement Resolution was approved [1]. - The Arrangement Resolution required at least 66⅔% of votes cast by shareholders, with 29,672,136 shares (approximately 66.93% of outstanding shares) represented at the meeting [2]. - The resolution was approved by 98.9% of the shares voted and 98.7% after excluding votes from interested parties as per MI 61-101 [2]. Group 2: Next Steps and Regulatory Approvals - The company is scheduled to seek a final order from the Supreme Court of British Columbia on March 5, 2026, to approve the arrangement [3]. - The completion of the arrangement is expected in the near term, pending satisfaction of all terms, conditions, and regulatory approvals [3]. Group 3: Company Overview - Quipt Home Medical Corp. provides in-home monitoring and disease management services, focusing on end-to-end respiratory solutions for patients in the U.S. healthcare market [5]. - The company aims to expand its offerings to manage various chronic diseases, enhancing shareholder value by providing a broader range of services [5]. - The organic growth strategy includes increasing annual revenue per patient by consolidating services and improving patient convenience [5].